Express Pharma
AUGUST 4, 2024
.” Dr Chandrashekar Ranga, Joint Drugs Controller, India, will discuss the obstacles regulators face in the digital era; Dr Stewart Geary, Global Safety Officer, Eisai and a Fellow of DIA, will provide updates on behalf of the Council for International Organizations of Medical Sciences (CIOMS) Working Group XII on Benefit-Risk Balance for Medicinal (..)
Express Pharma
JUNE 15, 2024
India, synonymous with the “pharmacy of the world” has rightfully earned the title, owing to its remarkable contribution in supplying 20 per cent of the global generic medicines, along with 60 per cent of the total vaccine demand worldwide.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 4, 2022
At Teva , he replaces Hafrun Fridriksdottir, a 25-year Teva veteran who was named R&D chief almost immediately after Kare Schultz took over the reins of Teva in 2017 with the task of turning around the fortunes of the ailing generics giant. ” The post Teva poaches Vertex exec as new head of R&D appeared first on.
Quality Matters
JUNE 26, 2023
Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need. EMA-FDA Parallel Scientific Advice: Optimizing Development of Medicines in the Global Age. link] (accessed on June 12, 2023) 2 Daan J.A. Crommelin, Vinod P. Shah, et al.
Quality Matters
APRIL 26, 2023
Essential elements of a strong, global medicines supply chain The U.S. Pharmacopeia (USP) has long been recognized as an international leader in medicines quality and supply chain integrity. in a platform that assesses the vulnerability of specific medicines to supply chain disruptions.
Express Pharma
SEPTEMBER 11, 2023
This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Prices of brands are paradoxically high Pharma contributes 43.2
Pharmaceutical Technology
MAY 3, 2023
In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines.
Expert insights. Personalized for you.
105 
Let's personalize your content